Evaluating the mechanistic role of NPY in cutaneous melanoma will determine whether this peptide may contribute or prevent disease and will indicate how this peptide could be targeted or used to combat disease pathogenesis and/or progression. Here, NPY is linked to cutaneous melanoma.